Cromos Pharma supporting clinical research to beat heart disease

World Heart Day (Wednesday, 29 September) is a day to raise awareness about the importance of your heart and ways to keep your heart healthy – no matter what age you are. It is also a day to recognize the incredible achievements in clinical research that have helped develop innovative therapies and treatments to improve the lives of patients with heart disease. Cromos Pharma is proud to play its part in supporting clinical research to make breakthroughs in the treatment of heart disease.

Global burden of cardiovascular disease

Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year[i]. CVD is an umbrella term for disorders of the heart and blood vessels. CVDs include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.

Worldwide over 500 million people are living with CVDs. Four out of five CVD deaths are due to heart attacks and strokes and one third of these deaths occur in people under 70 years of age.

Reducing your risks of heart disease

There are ways to reduce your risk of developing CVDs. Stopping smoking, reducing your intake of salt, eating more fruit and vegetables, getting regular physical activity and avoiding harmful use of alcohol have been shown to reduce the risk of cardiovascular disease.
Public health policies that support the adoption of “heart healthy” lifestyles and behaviors can also help address the global burden of CVDs. These include initiatives that make healthy eating choices more affordable, education programs from an early age on the risk factors for heart disease and support programs to help smoking cessation and reduction of alcohol consumption.

Clinical research and CVDs

Clinical research plays a vital role in addressing the global burden of CVDs by helping to identify causes and risks of heart diseases, developing innovative diagnostic tools to help detect CVDs earlier, and advancing novel therapies and treatments.

Cromos Pharma supporting CVD clinical trials

Cromos Pharma is proud to play its part in supporting clinical research to make breakthroughs in the treatment of CVDs. It has a strong track record over 16+ years of managing all aspects of cardiovascular clinical trials across all phases.

 

 ABOUT CROMOS PHARMA

Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 16 years’ experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

CONTACT US TODAY AT BD@CROMOSPHARMA.COM TO SET UP AN INTRODUCTORY MEETING TO EXPLORE HOW CROMOS PHARMA CAN SUPPORT YOUR NEXT CLINICAL PROJECT.

Source:

[i] https://www.who.int/health-topics/cardiovascular-diseases

CONTACT

BD@CROMOSPHARMA.COM

To arrange an introductory meeting and find out how our experience can benefit your next clinical project.